Expanding the clinical spectrum of biglycan-related Meester-Loeys syndrome

Josephina A. N. Meester,Anne Hebert,Maaike Bastiaansen,Laura Rabaut,Jarl Bastianen,Nele Boeckx,Kathryn Ashcroft,Paldeep S. Atwal,Antoine Benichou,Clarisse Billon,Jan D. Blankensteijn,Paul Brennan,Stephanie A. Bucks,Ian M. Campbell,Solène Conrad,Stephanie L. Curtis,Majed Dasouki,Carolyn L. Dent,James Eden,Himanshu Goel,Verity Hartill,Arjan C. Houweling,Bertrand Isidor,Nicola Jackson,Pieter Koopman,Anita Korpioja,Minna Kraatari-Tiri,Liina Kuulavainen,Kelvin Lee,Karen J. Low,Alan C. Lu,Morgan L. McManus,Stephen P. Oakley,James Oliver,Nicole M. Organ,Eline Overwater,Nicole Revencu,Alison H. Trainer,Bhavya Trivedi,Claire L. S. Turner,Rebecca Whittington,Andreas Zankl,Dominica Zentner,Lut Van Laer,Aline Verstraeten,Bart L. Loeys

DOI: https://doi.org/10.1038/s41525-024-00413-z

2024-03-27

npj Genomic Medicine

Abstract:Pathogenic loss-of-function variants in BGN , an X-linked gene encoding biglycan, are associated with Meester-Loeys syndrome (MRLS), a thoracic aortic aneurysm/dissection syndrome. Since the initial publication of five probands in 2017, we have considerably expanded our MRLS cohort to a total of 18 probands (16 males and 2 females). Segregation analyses identified 36 additional BGN variant-harboring family members (9 males and 27 females). The identified BGN variants were shown to lead to loss-of-function by cDNA and Western Blot analyses of skin fibroblasts or were strongly predicted to lead to loss-of-function based on the nature of the variant. No (likely) pathogenic missense variants without additional (predicted) splice effects were identified. Interestingly, a male proband with a deletion spanning the coding sequence of BGN and the 5' untranslated region of the downstream gene ( ATP2B3 ) presented with a more severe skeletal phenotype. This may possibly be explained by expressional activation of the downstream ATPase ATP2B3 (normally repressed in skin fibroblasts) driven by the remnant BGN promotor. This study highlights that aneurysms and dissections in MRLS extend beyond the thoracic aorta, affecting the entire arterial tree, and cardiovascular symptoms may coincide with non-specific connective tissue features. Furthermore, the clinical presentation is more severe and penetrant in males compared to females. Extensive analysis at RNA, cDNA, and/or protein level is recommended to prove a loss-of-function effect before determining the pathogenicity of identified BGN missense and non-canonical splice variants. In conclusion, distinct mechanisms may underlie the wide phenotypic spectrum of MRLS patients carrying loss-of-function variants in BGN .

genetics & heredity

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about the expansion of the clinical spectrum of Meester - Loeys syndrome (MRLS) and the functional analysis of its related gene variants. Specifically, the research aims to:

1. **Expand the clinical spectrum of MRLS patients**: By identifying more patients with BGN gene (encoding biglycan protein) variants and their family members, further describe in detail the clinical manifestations of MRLS. This includes but is not limited to aneurysms, aortic dissections, skeletal abnormalities and other connective tissue features.

2. **In - depth exploration of molecular mechanisms**: Conduct detailed molecular - level analysis of the identified BGN gene variants, including studies at the cDNA and protein levels, to demonstrate the specific mechanisms by which these variants lead to the loss of biglycan protein function. The study also pays special attention to the impact of certain specific gene variants (such as splice - site variants and missense variants) on biglycan expression.

3. **Clarify genotype - phenotype associations**: By analyzing the relationships between different types of BGN gene variants and specific clinical phenotypes, especially the mild skeletal dysplasia observed in male patients with partial BGN and ATP2B3 gene deletions, in order to discover more specific genotype - phenotype associations.

### Main findings
- **Diversity of clinical manifestations**: The study found that MRLS not only affects the thoracic aorta, but also involves aneurysms and dissections of the entire arterial tree. In addition, cardiovascular symptoms are often accompanied by non - specific connective tissue features.
- **Gender differences**: The clinical manifestations of male patients are more severe and prominent, while the phenotypes of female patients are more variable, ranging from asymptomatic to death due to aortic dissection.
- **Molecular mechanisms**: All identified BGN gene variants lead to the loss of biglycan protein function, which has been confirmed by cDNA and Western Blot analysis. For some specific gene variants, such as splice - site variants, abnormal biglycan protein expression has also been observed.
- **Abnormal expression of the ATP2B3 gene**: In some male patients with deletions in the 5' - untranslated region (5' - UTR) of the BGN gene and the ATP2B3 gene, abnormal expression of the ATP2B3 gene has been observed, which may explain the mild skeletal dysplasia in these patients.

### Conclusion
By expanding the cohort of MRLS patients and conducting detailed molecular and clinical analyses, this study not only deepens the understanding of the pathological mechanisms of MRLS, but also provides an important basis for future diagnosis and treatment. In particular, the study reveals that the loss of BGN gene function is the main pathogenic mechanism of MRLS, and discovers the associations between specific genotypes and clinical phenotypes, providing a new perspective for personalized medicine.